Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AST-120 in late-stage chronic kidney disease
NCT01681303Phase 4Completed
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Jan 2009
- Primary completion
- Sep 2011
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of activated charcoal in chronic kidney disease (CKD), sponsored by Chang Gung Memorial Hospital. Primary endpoint: Renal function change at 1 year. Started Jan 2009; status: completed.
02
Drugs
activated charcoal
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT01681303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01681303.